Companies: 10,795·Total market cap: $144.5T
InflaRx N.V.

InflaRx N.V.

IFRXNASDAQHealthcare● Active
$1.72
+$0.01(+0.29%)
Market Cap$123880543
P/E Ratio—
52W High$2.949
52W Low$0.741
Overview
Foreign Private Issuer · Files 20-F / 6-K

InflaRx N.V. (IFRX) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001708688 · IFRX · NASDAQ · as of Jun 9, 2026

Filing snapshot

275
Total Filings
SCHEDULE 13G
Latest Form
2026-05-14
Most Recent
2017
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001708688 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-03-20
Fiscal Year End
Mar 20, 2026
Accession No.
0001213900-26-032065
Primary Document
ea0281674-20f_inflarx.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001708688 · Accession 0001213900-26-032065

Latest Key Filings

6-KQuarterly Report
6-K
2026-05-07
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-14
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-12
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-07
View
424B5424B5
424B5
2026-05-07
View
424B5424B5
424B5
2026-05-06
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-06
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-06
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-04
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-28
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-23
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-09
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-02
View
20-FAnnual Report (Foreign Issuer)
ANNUAL REPORT
2026-03-20
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-19
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
Showing 1–15 of 275 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001708688  |  Exchange: NASDAQ · Healthcare

InflaRx N.V. (NASDAQ: IFRX) has submitted 275 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2017. As a Healthcare sector company with CIK 0001708688, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is InflaRx N.V.'s most comprehensive regulatory disclosure. The most recent InflaRx N.V. 10-K was filed on 2026-03-20 for fiscal year ending 2026. Historical IFRX 10-K annual reports are available from 2017 through 2026.

Investors researching InflaRx N.V. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
STRO SEC Filings →STTK SEC Filings →ARTV SEC Filings →CNTX SEC Filings →CNTB SEC Filings →KLRS SEC Filings →IMA SEC Filings →MGX SEC Filings →
→ IFRX Financials→ IFRX Earnings→ IFRX Insider Trades

Frequently Asked Questions

IFRX SEC Filings · 8 questions

InflaRx N.V. (IFRX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 275 filings and access original documents at no cost. InflaRx N.V.'s CIK is 0001708688.

IFRX SEC filingsInflaRx N.V. SEC documentsfind IFRX 10-K